|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn709718825 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110329s2010 dcua ob 100 0 eng d |
010 |
|
|
|a 2012419235
|
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d YDXCP
|d NATAP
|d OCLCQ
|d WVH
|d OCLCQ
|d OCLCA
|d NLGGC
|d OCLCO
|d MMU
|d KIJ
|d AU@
|d EBLCP
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d AZK
|d VT2
|d OCLCQ
|d AGLDB
|d TOA
|d MOR
|d OCLCA
|d LIP
|d OCLCO
|d PIFAG
|d MERER
|d ZCU
|d MERUC
|d OCLCQ
|d OCLCA
|d NJR
|d OCLCO
|d U3W
|d BUF
|d OCLCO
|d OCLCQ
|d OCLCO
|d CUY
|d OCLCO
|d OCLCQ
|d OCLCF
|d OCLCO
|d STF
|d WRM
|d VNS
|d OCLCO
|d OCLCQ
|d VTS
|d OCLCO
|d EZ9
|d OCLCQ
|d ICG
|d OCLCO
|d OCLCQ
|d OCLCO
|d WYU
|d S9I
|d UUM
|d TKN
|d OCLCQ
|d DKC
|d OCLCO
|d OCLCQ
|d M8D
|d OCLCO
|d UX1
|d OCL
|d OCLCQ
|d OCLCO
|d UKAHL
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d AJS
|d OCLCO
|d TUHNV
|d QGK
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|d OCLCQ
|d OCLCA
|d OCLCL
|
016 |
7 |
|
|a 101557455
|2 DNLM
|
019 |
|
|
|a 698271933
|a 764551188
|a 768691716
|a 771170667
|a 842259767
|a 961490255
|a 962604354
|a 971082927
|a 990383224
|a 1021269208
|a 1028813608
|a 1048150853
|a 1055330346
|a 1064737782
|a 1081197192
|a 1119430150
|a 1119441755
|a 1156358824
|a 1204377077
|a 1228536509
|a 1243598896
|a 1249234987
|a 1259186207
|
020 |
|
|
|a 9780309160223
|q (electronic bk.)
|
020 |
|
|
|a 0309160227
|q (electronic bk.)
|
020 |
|
|
|a 1282976001
|
020 |
|
|
|a 9781282976009
|
020 |
|
|
|a 9786612976001
|
020 |
|
|
|a 6612976004
|
020 |
|
|
|z 0309160219
|
020 |
|
|
|z 9780309160216
|
020 |
|
|
|a 0309186536
|
020 |
|
|
|a 9780309186537
|
029 |
1 |
|
|a AU@
|b 000050893576
|
029 |
1 |
|
|a AU@
|b 000051451154
|
029 |
1 |
|
|a DEBBG
|b BV043100772
|
029 |
1 |
|
|a DEBBG
|b BV044109165
|
029 |
1 |
|
|a DEBSZ
|b 421636262
|
029 |
1 |
|
|a DEBSZ
|b 449741915
|
029 |
1 |
|
|a NZ1
|b 13870275
|
029 |
1 |
|
|a AU@
|b 000075782273
|
035 |
|
|
|a (OCoLC)709718825
|z (OCoLC)698271933
|z (OCoLC)764551188
|z (OCoLC)768691716
|z (OCoLC)771170667
|z (OCoLC)842259767
|z (OCoLC)961490255
|z (OCoLC)962604354
|z (OCoLC)971082927
|z (OCoLC)990383224
|z (OCoLC)1021269208
|z (OCoLC)1028813608
|z (OCoLC)1048150853
|z (OCoLC)1055330346
|z (OCoLC)1064737782
|z (OCoLC)1081197192
|z (OCoLC)1119430150
|z (OCoLC)1119441755
|z (OCoLC)1156358824
|z (OCoLC)1204377077
|z (OCoLC)1228536509
|z (OCoLC)1243598896
|z (OCoLC)1249234987
|z (OCoLC)1259186207
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RA644.I6
|b A19 2010eb
|
060 |
|
4 |
|a 2011 D-257
|
060 |
|
4 |
|a QW 168.5.O7
|
072 |
|
7 |
|a MED
|x 076000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 030000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 078000
|2 bisacsh
|
082 |
0 |
4 |
|a 614.518
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
4 |
|a The 2009 H1N1 influenza vaccination campaign :
|b summary of a workshop series /
|c Clare Stroud, Lori Nadig, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
|
246 |
3 |
0 |
|a H1N1 influenza vaccination campaign
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2010.
|
300 |
|
|
|a 1 online resource (xiii, 126 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
504 |
|
|
|a Includes bibliographical references (pages 99-101).
|
505 |
0 |
|
|a Introduction -- Vaccine supply -- Vaccine distribution -- Implementation of ACIP recommendations -- Vaccine administration methods and partners -- Vaccination rates in certain populations -- Data collection, monitoring, evaluation, and use -- Communications and media -- Funding and payment issues -- Research and planning -- Final remarks.
|
520 |
|
|
|a "The 2009 H1N1 vaccination campaign was one of the largest public health campaigns in U.S. history, vaccinating one-quarter of the population in the first three months. The Institute of Medicine held three workshops in Raleigh, NC; Austin, TX; and Seattle, WA to learn from participants' experiences during the campaign and improve future emergency vaccination programs."
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a H1N1 influenza
|z United States
|x Prevention
|v Congresses.
|
650 |
|
0 |
|a Influenza vaccines
|z United States
|v Congresses.
|
650 |
|
0 |
|a Vaccination
|z United States
|v Congresses.
|
650 |
|
0 |
|a Viral vaccines.
|
650 |
|
0 |
|a Vaccination.
|
650 |
|
0 |
|a Respiratory infections.
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Immunization.
|
650 |
|
0 |
|a Respiratory organs
|x Diseases.
|
650 |
|
0 |
|a Virus diseases.
|
650 |
|
0 |
|a National health services.
|
650 |
|
0 |
|a Orthomyxoviruses.
|
650 |
|
0 |
|a Diseases.
|
650 |
|
0 |
|a Influenza.
|
650 |
|
0 |
|a Immunotherapy.
|
650 |
|
0 |
|a RNA viruses.
|
650 |
|
0 |
|a Public health.
|
650 |
|
0 |
|a Medical care.
|
650 |
|
0 |
|a Viruses.
|
650 |
|
0 |
|a Biological products
|x Therapeutic use.
|
650 |
|
0 |
|a Therapeutics.
|
650 |
|
0 |
|a Influenza vaccines.
|
650 |
|
0 |
|a Public health administration.
|
650 |
|
0 |
|a Medical care
|x Needs assessment.
|
651 |
|
0 |
|a North America.
|
650 |
|
0 |
|a Biologicals.
|
650 |
1 |
2 |
|a Influenza A Virus, H1N1 Subtype
|x prevention & control
|
650 |
1 |
2 |
|a Influenza A Virus, H1N1 Subtype
|
650 |
1 |
2 |
|a Influenza, Human
|x prevention & control
|
650 |
|
2 |
|a Influenza A virus
|
650 |
|
2 |
|a Viral Vaccines
|
650 |
|
2 |
|a Immunization Programs
|
650 |
|
2 |
|a Vaccination
|
650 |
|
2 |
|a Orthomyxoviridae Infections
|
650 |
|
2 |
|a Respiratory Tract Infections
|
650 |
|
2 |
|a Vaccines
|
650 |
|
2 |
|a Immunization
|
650 |
|
2 |
|a Immunotherapy, Active
|
650 |
|
2 |
|a Respiratory Tract Diseases
|
650 |
|
2 |
|a Preventive Health Services
|
650 |
|
2 |
|a RNA Virus Infections
|
650 |
|
2 |
|a Americas
|
650 |
|
2 |
|a Alphainfluenzavirus.
|
650 |
|
2 |
|a Virus Diseases
|
650 |
|
2 |
|a Biological Products
|
650 |
|
2 |
|a Health Services
|
650 |
|
2 |
|a Orthomyxoviridae
|
650 |
|
2 |
|a Primary Prevention
|
650 |
|
2 |
|a Disease
|
650 |
|
2 |
|a Geographic Locations
|
650 |
|
2 |
|a Community Health Services
|
650 |
|
2 |
|a Communicable Disease Control
|
650 |
|
2 |
|a Influenza, Human
|
650 |
|
2 |
|a Geographicals
|
650 |
|
2 |
|a Immunotherapy
|
650 |
|
2 |
|a Complex Mixtures
|
650 |
|
2 |
|a RNA Viruses
|
650 |
|
2 |
|a Public Health Practice
|
650 |
|
2 |
|a Health Care Facilities, Manpower, and Services
|
650 |
|
2 |
|a Immunologic Techniques
|
650 |
|
2 |
|a Public Health
|
650 |
|
2 |
|a Vertebrate Viruses
|
650 |
|
2 |
|a Delivery of Health Care
|
650 |
|
2 |
|a Immunomodulation
|
650 |
|
2 |
|a Chemicals and Drugs
|
650 |
|
2 |
|a Investigative Techniques
|
650 |
|
2 |
|a Viruses
|
650 |
|
2 |
|a Analytical, Diagnostic and Therapeutic Techniques and Equipment
|
650 |
|
2 |
|a Biological Therapy
|
650 |
|
2 |
|a Environment and Public Health
|
650 |
|
2 |
|a Organisms
|
650 |
|
2 |
|a Therapeutics
|
650 |
2 |
2 |
|a Influenza Vaccines
|
650 |
2 |
2 |
|a Mass Vaccination
|
650 |
2 |
2 |
|a Public Health Administration
|
650 |
2 |
2 |
|a Health Services Needs and Demand
|
651 |
|
2 |
|a United States
|
651 |
|
2 |
|a North America
|
650 |
|
2 |
|a Respiration Disorders
|
650 |
|
2 |
|a State Medicine
|
650 |
|
2 |
|a Patient Care
|
650 |
|
6 |
|a Vaccins antigrippaux
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Vaccination
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Influenzavirus A (H1N1)
|
650 |
|
6 |
|a Vaccins antiviraux.
|
650 |
|
6 |
|a Vaccination.
|
650 |
|
6 |
|a Appareil respiratoire
|x Infections.
|
650 |
|
6 |
|a Vaccins.
|
650 |
|
6 |
|a Immunisation.
|
650 |
|
6 |
|a Appareil respiratoire
|x Maladies.
|
650 |
|
6 |
|a Maladies à virus.
|
650 |
|
6 |
|a Services de santé.
|
650 |
|
6 |
|a Orthomyxovirus.
|
650 |
|
6 |
|a Maladies.
|
650 |
|
6 |
|a Grippe.
|
650 |
|
6 |
|a Immunothérapie.
|
650 |
|
6 |
|a Virus à ARN.
|
650 |
|
6 |
|a Santé publique.
|
650 |
|
6 |
|a Prestation de soins.
|
650 |
|
6 |
|a Virus.
|
650 |
|
6 |
|a Biothérapie.
|
650 |
|
6 |
|a Thérapeutique.
|
650 |
|
6 |
|a Vaccins antigrippaux.
|
650 |
|
6 |
|a Santé publique
|x Administration.
|
650 |
|
6 |
|a Soins médicaux
|x Analyse des besoins.
|
651 |
|
6 |
|a Amérique du Nord.
|
650 |
|
6 |
|a Soins médicaux.
|
650 |
|
6 |
|a Médicaments biologiques.
|
650 |
|
7 |
|a disease.
|2 aat
|
650 |
|
7 |
|a illness.
|2 aat
|
650 |
|
7 |
|a public health.
|2 aat
|
650 |
|
7 |
|a treating (health care function)
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Preventive Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Forensic Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Public Health.
|2 bisacsh
|
650 |
|
7 |
|a Viruses
|2 fast
|
650 |
|
7 |
|a Virus diseases
|2 fast
|
650 |
|
7 |
|a Viral vaccines
|2 fast
|
650 |
|
7 |
|a Vaccines
|2 fast
|
650 |
|
7 |
|a Therapeutics
|2 fast
|
650 |
|
7 |
|a RNA viruses
|2 fast
|
650 |
|
7 |
|a Respiratory organs
|x Diseases
|2 fast
|
650 |
|
7 |
|a Respiratory infections
|2 fast
|
650 |
|
7 |
|a Public health administration
|2 fast
|
650 |
|
7 |
|a Public health
|2 fast
|
650 |
|
7 |
|a Orthomyxoviruses
|2 fast
|
650 |
|
7 |
|a National health services
|2 fast
|
650 |
|
7 |
|a Medical care
|x Needs assessment
|2 fast
|
650 |
|
7 |
|a Medical care
|2 fast
|
650 |
|
7 |
|a Influenza
|2 fast
|
650 |
|
7 |
|a Immunotherapy
|2 fast
|
650 |
|
7 |
|a Immunization
|2 fast
|
650 |
|
7 |
|a Diseases
|2 fast
|
650 |
|
7 |
|a Biological products
|x Therapeutic use
|2 fast
|
650 |
|
7 |
|a Influenza vaccines
|2 fast
|
650 |
|
7 |
|a Vaccination
|2 fast
|
651 |
|
7 |
|a North America
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd
|
651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
655 |
|
2 |
|a Congress
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
700 |
1 |
|
|a Stroud, Clare.
|
700 |
1 |
|
|a Nadig, Lori.
|
700 |
1 |
|
|a Altevogt, Bruce M.
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Forum on Medical and Public Health Preparedness for Catastrophic Events.
|
758 |
|
|
|i has work:
|a The 2009 H1N1 influenza vaccination campaign (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFvGtyQvGttgb4QxqWJT6q
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t 2009 H1N1 influenza vaccination campaign.
|d Washington, D.C. : National Academies Press, ©2010
|z 9780309160216
|w (OCoLC)694600796
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378725
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36617300
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36559487
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3378725
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10443267
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 354519
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3753771
|
994 |
|
|
|a 92
|b IZTAP
|